WGS Stock Analysis: Buy, Sell, or Hold?
WGS - GeneDx Holdings Corp. Class A Common Stock
$96.26
-1.90 (-1.94%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 23, 2026
23d
Get Alerted When WGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: WGS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: WGS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.96
Based on -25.4% avg growth
INTRINSIC VALUE TODAY
$1.84
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WGS is currently trading at $96.26, which is considered oversold relative to its 30-day fair value range of $101.77 to $134.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 156.3) compared to its historical average (285.5). Remarkably, the market is currently pricing in an annual earnings decline of 18.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, WGS is in a strong uptrend. Immediate support is located at $91.65, while resistance sits at $113.23.
Market Sentiment: WGS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $170.00 (+73.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, WGS is in a strong uptrend. Immediate support is located at $91.65, while resistance sits at $113.23.
Market Sentiment: WGS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $170.00 (+73.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$101.77 -
$134.15
Company Quality Score
44/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding WGS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 73.2% below Wall St target ($170.00)
- CAUTION: 5-day price weakness (-5.0%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$101.77 -
$134.15
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$15.21
(15.8%)
Support & Resistance Levels
Support Level
$91.65
Resistance Level
$113.23
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
156.31
Wall Street Target
$170.00
(+73.2%)
Revenue Growth (YoY)
51.9%
Profit Margin
0.5%
Valuation Discount vs History
-18.2% cheaper
PE vs Historical
156.3 vs 285.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-18.2%
(market-implied from PE analysis)
1-Year Target
$88.34
(-10%)
2-Year Target
$79.51
(-19%)
3-Year Target
$71.56
(-27%)
3-Yr Target (if PE normalizes)
(PE: 156→286)
$130.71
(+33%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 156.3, Growth: -54.7%)
$71.56
(+-27%)
Base:
(SPY PE: 22.3, Growth: -54.7%)
$10.21
(-90%)
Bear:
(PE: 19.0, Growth: -54.7%)
$8.68
(-91%)
📈
Valuation based on Current Earnings
Forward PE: 82.64 | Forward EPS (Implied): $1.19
Bull Case
$118.53
(+21%)
Analyst growth 15.0%, PE expands to 86.8
Base Case
$98.16
(0%)
Market implied 0.0%, PE stable at 82.6
Bear Case
$75.09
(-24%)
Severe decline -15.0%, PE contracts to 74.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 156.3 to 285.5
Stabilization Target:
$179.29
(+82.7%)
PE Expansion Potential:
+82.7%
Last updated: January 30, 2026 5:36 PM ET
Data refreshes hourly during market hours. Next update: 6:36 PM
Data refreshes hourly during market hours. Next update: 6:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Katherine Stueland
SELL
10501 shares
2025-09-16
Kevin Feeley
SELL
3728 shares
2025-09-16
Kevin Feeley
SELL
378 shares
2025-09-02
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$121 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$263 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |
Advanced WGS Option Strategies
Professional options setups generated by AI based on today's WGS price and gamma walls.
